Health Information
Health Information
Melphalan 認識化療藥品Melphalan
2024/1/22Melphalan is an alkylating agent that exerts its anticancer activity by reacting with DNA and interfering with DNA replication and cell division. This stops the growth and spread of cancer cell in the body.
Nivolumab 認識標靶藥品Nivolumab
2024/1/22Nivolumab is a monoclonal antibody that binds to PD-1 (Programmed cell death protein 1) and blocks its interaction with PD-L1 (programmed cell death ligand 1).
Obinutuzumab 認識標靶藥品Obinutuzumab
2024/1/22Obinutuzumab is a monoclonal antibody that targets to a protein called CD20 on the surface of white blood cells known as B lymphocytes. When obinutuzumab attaches to the surface of these cells, the abnormal growth of the B lymphocytes is stopped.
Olaratumab 認識化療藥品Olaratumab
2024/1/22Olaratumab is a monoclonal antibody that binds to platelet-derived growth factor receptor-alpha (PDGFRα), which locates on the surface of cancer cells. This drug blocks the activation of PDGFRα, thus inhibiting cell proliferation and tumor growth.
Irinotecan liposome 認識化療藥品Onivyde
2024/1/22Onivyde® is irinotecan covered in tiny spheres called liposomes. These spheres keep irinotecan in the bloodstream longer and help irinotecan get through the dense stroma of the pancreatic tumor, thus significantly enhancing the efficacy of irinotecan in tumor tissue.
Paclitaxel 認識化療藥品Paclitaxel
2024/1/22Paclitaxel is a plant alkaloid derived from the bark of the Pacific Yew tree. Paclitaxel inhibits the action of proteins called microtubules for cell division, thus stopping cancer cells from separating into two new cells, eventually causing cell death.
Panitumumab 認識標靶藥品Panitumumab
2024/1/22Panitumumab is a monoclonal antibody which targets the epidermal growth factor receptor (EGFR) on cells. EGFR is found in large amounts on the surface of some cancer cells, resulting in tumors growing more quickly.
Pembrolizumab 認識標靶藥品Pembrolizumab
2024/1/22Pembrolizumab is a monoclonal antibody that binds to PD-1 (Programmed cell death protein 1) and blocks its interaction with PD-L1 (programmed cell death ligand 1).
Pemetrexed 認識化療藥品Pemetrexed
2024/1/22Pemetrexed belongs to a group of drugs called antimetabolites. It exerts its anti-cancer effects by inhibiting production of folate that is essential for the formation of DNA and RNA.This cell damage stops the growth of cancer cells, causing the cells to die.
Pertuzumab 認識標靶藥品Pertuzumab
2024/1/22Pertuzumab is a monoclonal antibody which targets the human epidermal growth factor receptor 2 (HER2) on cells. HER2 is found in large amounts on the surface of some cancer cells, resulting in tumors growing more quickly.